Delivery Order SPE2DB22D3501-SPE2DB25FWU93
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 7, 2025, by the Defense Logistics Agency for $50,225.55 to supply Biktarvy 50-200-25 mg tablets in quantities of 30. This firm fixed-price delivery order, which is not set-aside designated, is expected to be completed by August 8, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a continuation of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count unit dose packages) valued at $28,563.74. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency (DLA), a defense agency responsible for supplying pharmaceuticals and medical materiel to military health systems. The contract is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) valued at $1,548.16 for Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract is classified as a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and no set-aside designation. The award serves the federal medical supply chain supporting military and veteran healthcare systems through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $66,709.27, was competitively awarded with no set-aside designation and is scheduled for completion by August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency (DLA) for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $12,635.27, is set to be completed by August 13, 2025, and represents performance at the company's Conshohocken facility. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $34.5K delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets in 30-unit packages. This non-set-aside, firm fixed-price contract represents a delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $134,559.71 on August 13, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $80,409.74 to supply Biktarvy 50-200-25 mg tablets (30-count bottles) under a firm fixed-price contract with an ultimate completion date of August 4, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- AmerisourceBergen Drug Corp received a delivery order valued at $7,766.20 from the Defense Logistics Agency (DLA) on August 5, 2025, with an ultimate completion date of August 6, 2025. The contract covers the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through the DLA's procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,394.87 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, utilizes firm fixed price terms with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWU93Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $62,597.51 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a relatively small transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support is developing next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with plans for multiple regional awards, positioning AmerisourceBergen to continue serving critical federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62.6k | 8/11/25 |